Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Expects FDA Orthopedics Panel Review For InFuse Bone Graft

This article was originally published in The Gray Sheet

Executive Summary

Medtronic's Sofamor Danek division is anticipating that FDA's Orthopedics and Rehabilitation Devices Advisory Panel will review the firm's PMA submission for the use of InFuse bone graft system in spinal fusion procedures, company officials said

You may also be interested in...



Synthes Chooses Alternative-To-BMP Route In Bone Growth Factor Search

Synthes-Stratec plans to forego immediate development of an orthobiologic bone growth factor, citing doubts about the product's feasibility in musculoskeletal repair applications

Synthes Chooses Alternative-To-BMP Route In Bone Growth Factor Search

Synthes-Stratec plans to forego immediate development of an orthobiologic bone growth factor, citing doubts about the product's feasibility in musculoskeletal repair applications

Wyeth BMP-2 Should Be Limited To “Problem” Fractures – Panel

Wyeth's InductOs recombinant human bone morphogenic protein-2 indications for use should be limited to "problem" fractures, according to FDA's Orthopaedic and Rehabilitation Devices Panel

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel